---

 

 

 

 

The Task Force on Geroscience Pre-Clinical and Clinical Trials will convene in Toulouse, France, on March 12, 2025, immediately preceding the International Conference on Frailty and Sarcopenia Research (ICFSR 2025). 

 

The previous Task Force reports have been published in Nature Communications Read the article and Nature Aging Read the article. These reports provide valuable insights into the advancements in Geroscience and drug development for healthy aging.  The 2024 ICFSR/Geroscience Task Force progam and participants can be found HERE

 

The primary objective of the Task Force is to bring together prominent thought leaders from both academia and industry, all of whom are actively engaged in geroscience research. Our goal is to facilitate a robust exchange of ideas and foster productive discussions that will drive the development of novel therapeutic strategies and innovative approaches to promote healthy aging. 

 

We look forward to your potential contribution to this important dialogue and to the advancement of scientific research in this field. 

 

The Geroscience Task Force Chairs 
Pr. Roger Fielding, PhD – Tufts University (Boston – USA)
Pr. Bruno Vellas – IHU HealthAge (Toulouse – France) 

 

 

 

---